Monday, December 10, 2012

• Pick Up This Deal Even Lower Than Director Dougherty Didat Forbes (Mon, Dec 10)

Wednesday, December 5, 2012

• The Worst of 2012: Halozyme Therapeuticsat Motley Fool (Wed, Dec 5)

Wednesday, November 28, 2012

• ViroPharma reverses stock skid, a bit, after upgradeat bizjournals.com (Wed, Nov 28)

Tuesday, November 27, 2012

• Why the Street Should Love ViroPharma's Earningsat Motley Fool (Tue, Nov 27)
• ViroPharma rises following analyst upgradeAP (Tue, Nov 27)
• Fresenius Medical Care AG & Co and More Big Movers in Healthcare on November 27, 2012at Investopedia (Tue, Nov 27)

Sunday, November 25, 2012

• 2 Important Decisions to Watch For This Week in the Biotech Sectorat Motley Fool (Sun, Nov 25)

Monday, November 19, 2012

• ViroPharma Inc. Stock Downgraded (VPHM)at TheStreet (Mon, Nov 19)

Friday, November 16, 2012

• Tesoro Initiated at In-Line and 3 Must-See Initiated Sharesat Wall St. Cheat Sheet (Fri, Nov 16)

Thursday, November 15, 2012

• The Zacks Analyst Blog Highlights: ViroPharma Inc, Halozyme Therapeutics, Lockheed Martin Corporation, The Boeing Company and General Dynamics CorporationZacks (Thu, Nov 15)

Wednesday, November 14, 2012

• ViroPharma Presents Cinryze DataZacks (Wed, Nov 14)

Thursday, November 8, 2012

• This Hedge Fund's Picks Have Returned 20% Two Straight Quartersat Motley Fool (Thu, Nov 8)

Thursday, November 1, 2012

• Watson Beats, Revises OutlookZacks (Thu, Nov 1)

Wednesday, October 31, 2012

• BioMarin Earnings: 3 Keys from Q3at Motley Fool (Wed, Oct 31)

Monday, October 29, 2012

• Revenues Fall at ViroPharmaZacks (Mon, Oct 29)

Friday, October 26, 2012

• ViroPharma Goes Redat Motley Fool (Fri, Oct 26)
• ViroPharma Management Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Fri, Oct 26)

Thursday, October 25, 2012

• ViroPharma upgraded to Outperform from Perform at Oppenheimertheflyonthewall.com (Thu, Oct 25)
• VIROPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Thu, Oct 25)
• ViroPharma sees FY12 worldwide net product sales $425M-$435Mtheflyonthewall.com (Thu, Oct 25)
• ViroPharma reports Q3 Cinryze revenue $85.3Mtheflyonthewall.com (Thu, Oct 25)

Monday, October 22, 2012

• ViroPharma’s Cinryze for HAE approved in Canadaat bizjournals.com (Mon, Oct 22)

Saturday, October 20, 2012

• Has Optimer Pharmaceuticals Become the Perfect Stock?at Motley Fool (Sat, Oct 20)

Friday, October 12, 2012

• Is ViroPharma Going to Burn You?at Motley Fool (Fri, Oct 12)

Wednesday, October 3, 2012

• VIROPHARMA INC Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online (Wed, Oct 3)

Add VPHM News to My Yahoo!